Skip to content

Perceptive Advisors portfolio · Q3 2026

Perceptive Advisors LLC · CIK 0001224962 ·13F filings on SEC EDGAR

In Q3 2026, Perceptive Advisors LLC reported 108 positions worth $5.7B. Its largest holding was PRAX at 10.3% of the portfolio, and the top 10 made up 50%. Its largest new position was FRNM ($198.5M), and it sold out of NUVL.

Portfolio value
$5.7B
Positions
108
Top 10 share
49.7%
Changes vs Jun 30, 2026
  • NEW 26
  • ADD 15
  • REDUCE 42
  • EXIT 27

Portfolio map

NEWADDHOLDREDUCE

Each box is a position sized by its value. Color shows the change in shares from the previous quarter. The smallest 68 positions are grouped as one box.

Portfolio history

Q4 2025 to Q3 2026, 4 quarters

Weight of the largest holdings

The 7 holdings with the highest weight in any quarter shown, stacked with all others to 100%.

PRAXCELCASCENDIS PHARMA A/SSYREAMLXRYTMMRNA PutOther

Holding timeline

Shade shows the weight in each quarter. A blank cell means the holding was not reported that quarter.

< 1%1–3%3–6%6–10%10–20%20–35%≥ 35%

Holdings

Click a holding to see its price chart with the quarters the investor bought or sold.

NameWeightAvg. cost (est.)Latest priceGain/lossValue
MRNAPut
MODERNA INC
4.70%———$269.6M
SLSCall
SELLAS LIFE SCIENCES GROUP I
0.64%———$36.9M
XBIPut
SS SPDR S&P BIOTECH ETF
0.55%———$31.5M
SLSPut
SELLAS LIFE SCIENCES GROUP I
0.54%———$30.8M
NAMSPut
NEWAMSTERDAM PHARMA CO NV
0.25%———$14.6M
15102KAA8
Celcuity Inc.
PRN
0.20%———$11.7M
EYPTPut
EYEPOINT INC
0.20%———$11.4M
BHVNPut
BIOHAVEN LTD
0.05%———$2.7M
EYPTCall
EYEPOINT INC
0.04%———$2.4M

Average cost is an estimate, not the investor's actual purchase price: every quarter the share count rose, the added shares are counted at that quarter-end's 13F price, and sales keep the average. Latest price is the most recent 13F quarter-end price (Sep 30, 2026), and value is shares × latest price.

Changes in shares

Change in shares held vs Jun 30, 2026, for the 20 largest positions that changed. Bars are capped at ±100%; the label shows the actual change.

NEWADDREDUCEEXIT

Sold out this quarter

Held on Jun 30, 2026 and not reported for Q3 2026.

StockPrior weightPrior sharesPrior valueChange
NUVL
NUVALENT INC-A
2.93%1,580,505$195.2MEXIT
APGE
APOGEE THERAPEUTICS INC
2.61%1,308,113$173.6MEXIT
IONS
IONIS PHARMACEUTICALS INC
0.67%566,000$44.9MEXIT
JAZZ
JAZZ PHARMACEUTICALS PLC
0.61%170,000$41MEXIT
SION
SIONNA THERAPEUTICS INC
0.60%905,000$39.8MEXIT
CORT
CORCEPT THERAPEUTICS INC
0.52%398,385$34.6MEXIT
36322Q206
DAMORA THERAPEUTICS INC
0.48%1,223,000$31.8MEXIT
CRL
CHARLES RIVER LABORATORIES
0.48%140,000$31.8MEXIT
AXSM
AXSOME THERAPEUTICS INC
0.44%118,450$29MEXIT
TENX
TENAX THERAPEUTICS INC
0.37%1,700,000$24.7MEXIT
CAPRCall
CAPRICOR THERAPEUTICS INC
0.36%1,000,000$24.1MEXIT
ISRG
INTUITIVE SURGICAL INC
0.31%51,884$20.6MEXIT
CTNM
CONTINEUM THERAPEUTICS INC-A
0.31%1,255,592$20.6MEXIT
OMDA
OMADA HEALTH INC
0.26%786,330$17.3MEXIT
CAPRPut
CAPRICOR THERAPEUTICS INC
0.18%500,000$12MEXIT
OSCR
OSCAR HEALTH INC - CLASS A
0.17%400,000$11.4MEXIT
BSX
BOSTON SCIENTIFIC CORP
0.16%250,000$10.7MEXIT
NTRA
NATERA INC
0.14%34,689$9.4MEXIT
RACC
RESEARCH ALLIANCE CORP CL A
0.12%750,000$8MEXIT
CGEM
CULLINAN THERAPEUTICS INC
0.12%426,478$7.8MEXIT
PHAT
PHATHOM PHARMACEUTICALS INC
0.09%532,000$5.8MEXIT
COGT
COGENT BIOSCIENCES INC
0.07%121,082$4.7MEXIT
AVTX
AVALO THERAPEUTICS INC
0.06%219,813$4.1MEXIT
TWST
TWIST BIOSCIENCE CORP
0.06%36,812$3.8MEXIT
BDSX
BIODESIX INC
0.04%108,694$2.5MEXIT
CPIX
CUMBERLAND PHARMACEUTICALS
0.01%96,982$628.4KEXIT
SRZNW
SURROZEN INC-CW25
0.00%166,666$2.8KEXIT

SEC filings for Q3 2026